OncoDaily

@oncodaily.bsky.social

1 hour ago

Estela Rodriguez Invites Participation in Miami Precision Medicine Conference 2026 - OncoDaily Estela Rodriguez Invites Participation in Miami Precision Medicine Conference 2026 / cancer, Estela Rodriguez, OncoDaily, Oncology, Precision Medicine

Estelamari Rodriguez Invites Participation in Miami Precision Medicine Conference 2026

@latinamd.bsky.social

oncodaily.com/voices/estel...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews

OncoDaily

@oncodaily.bsky.social

1 hour ago

Yan Leyfman: Gene Editing Rapidly Redefines What is Possible in Sickle Cell Disease - OncoDaily Yan Leyfman: Gene Editing Rapidly Redefines What is Possible in Sickle Cell Disease / Akshay Sharma, Baisong Mei, cancer, Christopher McKinney, CRISPR-Cas12a,

Gene Editing Rapidly Redefines What is Possible in Sickle Cell Disease - Yan Leyfman

@yleyfman.bsky.social

oncodaily.com/voices/yan-l...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews

OncoDaily

@oncodaily.bsky.social

2 hours ago

Stephen Liu: Real World Outcomes With Tarlatamab From Alissa Cooper - OncoDaily Stephen Liu: Real World Outcomes With Tarlatamab From Alissa Cooper / Alissa Cooper, Alissa J. Cooper, Andrea Arfe, Bobby Daly, cancer, Catherine B. Meador,

Real World Outcomes With Tarlatamab From Alissa Cooper - Stephen Liu

@stephenvliu.bsky.social

oncodaily.com/voices/aliss...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews

OncoDaily

@oncodaily.bsky.social

3 hours ago

Julie Gralow: Advocating for Sustained Federal Investment in Cancer Research - OncoDaily Julie Gralow: Advocating for Sustained Federal Investment in Cancer Research / cancer, Julie Gralow, NCI, NIH, OncoDaily, Oncology

Advocating for Sustained Federal Investment in Cancer Research - Julie Gralow

@jrgralow.bsky.social

oncodaily.com/voices/julie...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews

OncoDaily

@oncodaily.bsky.social

3 hours ago

Vivek Subbiah: Tumor-Agnostic Therapies and the Need for Living Guidelines - OncoDaily Vivek Subbiah: Tumor-Agnostic Therapies and the Need for Living Guidelines / ASCO, cancer, Jim Palma, OncoDaily, Oncology, Razelle Kurzrock, Thomas K. Oliver,

Tumor-Agnostic Therapies and the Need for Living Guidelines - Vivek Subbiah

@viveksubbiah.bsky.social @ascocancer.bsky.social

oncodaily.com/voices/vivek...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews

OncoDaily

@oncodaily.bsky.social

3 hours ago

Maria Babak: FDA Approves Tecartus in Relapsed or Refractory Mantle Cell Lymphoma - OncoDaily Maria Babak: FDA Approves Tecartus in Relapsed or Refractory Mantle Cell Lymphoma / cancer, FDA, Maria Babak, OncoDaily, Oncology, Tecartus, The Babak Lab

FDA Approves Tecartus in Relapsed or Refractory Mantle Cell Lymphoma - Maria Babak

@thebabaklab.bsky.social

oncodaily.com/voices/maria...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews

OncoDaily

@oncodaily.bsky.social

3 hours ago

Registration Open for Leadership Meeting Open Plenary Session - Common Sense Oncology - OncoDaily Registration Open for Leadership Meeting Open Plenary Session - Common Sense Oncology / cancer, Common Sense Oncology, Fidel Rubagumya, Jennifer Miller,

Common Sense Oncology - Registration Open for Leadership Meeting Open Plenary Session

@csoncol.bsky.social

oncodaily.com/voices/commo...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews

OncoDaily

@oncodaily.bsky.social

1 day ago

Balazs Halmos: The Patient With A Broken Heart - Complex Lung Cancer Case With Cardiac Invasion - OncoDaily Balazs Halmos: The Patient With A Broken Heart - Complex Lung Cancer Case With Cardiac Invasion / Balazs Halmos, cancer, OncoDaily, Oncology

The Patient With A Broken Heart – Complex Lung Cancer Case With Cardiac Invasion - Balazs Halmos

@balazshalmos.bsky.social

oncodaily.com/voices/balaz...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews

OncoDaily

@oncodaily.bsky.social

1 day ago

Celia Diez de los Rios: Lessons from the “Good Day Project” - OncoDaily Celia Diez de los Rios: Lessons from the “Good Day Project” / Amanda Drury, cancer, Celia Diez de los Rios, Daniel Kelly OBE, EONS, Grigorios Kotronoulas,

Lessons from the “Good Day Project” - Celia Diez de los Rios

@celiadr.bsky.social

oncodaily.com/voices/celia...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews

OncoDaily

@oncodaily.bsky.social

1 day ago

Yan Leyfman: Epcoritamab Integrated Upfront into Salvage Therapy in R/R DLBCL - OncoDaily Yan Leyfman: Epcoritamab Integrated Upfront into Salvage Therapy in R/R DLBCL / cancer, Chan Y. Cheah, Daniel Morillo, David Lewis, Fritz Offner, Gerardo

Epcoritamab Integrated Upfront into Salvage Therapy in R/R DLBCL - Yan Leyfman

@yleyfman.bsky.social

oncodaily.com/voices/yan-l...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews

OncoDaily

@oncodaily.bsky.social

1 day ago

“A Day to Remember” Through the 12 People 12 Cameras 12 Months Project - UICC - OncoDaily “A Day to Remember” Through the 12 People 12 Cameras 12 Months Project - UICC / cancer, OncoDaily, Oncology, UICC

UICC - “A Day to Remember” Through the 12 People 12 Cameras 12 Months Project

@uiccofficial.bsky.social

oncodaily.com/voices/uicc-...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews

OncoDaily

@oncodaily.bsky.social

1 day ago

Stephen Liu: First-Line Immunotherapy in KRAS G12C NSCLC - OncoDaily Stephen Liu: First-Line Immunotherapy in KRAS G12C NSCLC / Alessandra Bearz, Ana Giménez-Capitán, Anna Koumarianou, cancer, Chiara Lazzari, Congqiao Zhao,

First-Line Immunotherapy in KRAS G12C NSCLC - Stephen Liu

@thelancetoncol.bsky.social @stephenvliu.bsky.social

oncodaily.com/voices/steph...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews

OncoDaily

@oncodaily.bsky.social

1 day ago

Ramy Sedhom: The Grey Area in Hormone Replacement Therapy After Breast Cancer - OncoDaily Ramy Sedhom: The Grey Area in Hormone Replacement Therapy After Breast Cancer / Breast Cancer, cancer, Don S. Dizon, hormone therapy, Journal of Clinical

The Grey Area in Hormone Replacement Therapy After Breast Cancer - Ramy Sedhom

@rsedhom.bsky.social

oncodaily.com/voices/ramy-...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #HormoneTherapy #TreatmentPersonalization #BreastCancer

OncoDaily

@oncodaily.bsky.social

1 day ago

A New Possibility for People Living with ALK+ Lung Cancer - Oncogene Cancer Research - OncoDaily A New Possibility for People Living with ALK+ Lung Cancer - Oncogene Cancer Research / cancer, Lung cancer, OncoDaily, Oncogene Cancer Research, Oncology

Oncogene Cancer Research - A New Possibility for People Living with ALK+ Lung Cancer

@oncogenecancer.bsky.social

oncodaily.com/voices/oncog...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #CancerResearch #LungCancer

OncoDaily

@oncodaily.bsky.social

2 days ago

Bristol Myers Squibb: Augtyro Listed on PBS for ROS1-Positive NSCLC - OncoDaily Bristol Myers Squibb: Augtyro Listed on PBS for ROS1-Positive NSCLC / A John Iafrate, Adriana Gonzalez, Alice T Shaw, Augtyro, Bristol Myers Squibb, cancer,

Bristol Myers Squibb - Augtyro Listed on PBS for ROS1-Positive NSCLC

@bms-news.bsky.social

oncodaily.com/voices/brist...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #Repotrectinib #RareCancer #NSCLC

OncoDaily

@oncodaily.bsky.social

2 days ago

Paolo Tarantino: Median PFS With Standard First Line Treatments in HER2+ MBC - OncoDaily Paolo Tarantino: Median PFS With Standard First Line Treatments in HER2+ MBC / cancer, Dana-Farber Cancer Institute, Elad Sharon, OncoDaily, Oncology, Paolo

Median PFS With Standard First Line Treatments in HER2+ MBC - Paolo Tarantino

@ptarantinomd.bsky.social

oncodaily.com/voices/paolo...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews

OncoDaily

@oncodaily.bsky.social

2 days ago

Sharlene Gill: EmpowerHER Oncology Summit to Advance Women’s Health in Cancer Care - OncoDaily Sharlene Gill

EmpowerHER Oncology Summit to Advance Women’s Health in Cancer Care - Sharlene Gill

@gillsharlene.bsky.social

oncodaily.com/voices/sharl...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews

OncoDaily

@oncodaily.bsky.social

2 days ago

Yan Leyfman: Teaching Cancer-Fighting Cells to Recharge - OncoDaily Yan Leyfman: Teaching Cancer-Fighting Cells to Recharge / cancer, CAR-T cells, Jeremy Bellaiche, OncoDaily, Oncology, Shuf, Yan Leyfman

Teaching Cancer-Fighting Cells to Recharge - Yan Leyfman

@yleyfman.bsky.social

oncodaily.com/voices/yan-l...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews

OncoDaily

@oncodaily.bsky.social

2 days ago

Early Registration Open for ESMO Examination 2026 - OncoDaily Early Registration Open for ESMO Examination 2026 / cancer, ESMO, OncoDaily, Oncology

Early Registration Open for ESMO Examination 2026

@myesmo.bsky.social

oncodaily.com/voices/esmo-...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews

OncoDaily

@oncodaily.bsky.social

2 days ago

FDA Approves New Combination Therapy for Platinum-Resistant Ovarian Cancer - OCRF - OncoDaily FDA Approves New Combination Therapy for Platinum-Resistant Ovarian Cancer - OCRF / cancer, FDA, OncoDaily, Oncology, Ovarian Cancer, Ovarian Cancer Research

OCRF - FDA Approves New Combination Therapy for Platinum-Resistant Ovarian Cancer

@ocrfaustralia.bsky.social

oncodaily.com/voices/ocrf-...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #OvarianCancer #CancerResearch #Ommunotherapy

OncoDaily

@oncodaily.bsky.social

2 days ago

KANDLELIT-001: Calderasib Shows Strong Activity in NSCLC KANDLELIT-001 trial shows Calderasib plus pembrolizumab achieves up to 92% ORR in KRAS G12C NSCLC

SIOP - PARC Early Career Award 2026

@worldsiop.bsky.social

oncodaily.com/voices/siop-...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews

OncoDaily

@oncodaily.bsky.social

3 days ago

Daniela Urueta Portillo and Stephanie Haddad Selected Chief Fellows 2026–2027 at UT Health San Antonio - OncoDaily Daniela Urueta Portillo and Stephanie Haddad Selected Chief Fellows 2026–2027 at UT Health San Antonio / cancer, Daniela Urueta Portillo, OncoDaily, Oncology,

Daniela Urueta Portillo and Stephanie A. Haddad, DO Selected Chief Fellows 2026–2027 at UT Health San Antonio

@drshaddad.bsky.social

oncodaily.com/voices/danie...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews

OncoDaily

@oncodaily.bsky.social

3 days ago

Gevorg Tamamyan: Great Things Are Coming to Paris! - OncoDaily Gevorg Tamamyan: Great Things Are Coming to Paris! / Aminata Dia, cancer, Elie Rassy, Gevorg Tamamyan, Gustave Roussy, OncoDaily, Oncology, Paris

Great Things Are Coming to Paris! - Gevorg Tamamyan

@gevorgtamamyan.bsky.social

oncodaily.com/voices/gevor...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews

OncoDaily

@oncodaily.bsky.social

3 days ago

Paolo Tarantino: Median PFS With Standard First Line Treatments in HER2+ MBC - OncoDaily Paolo Tarantino: Median PFS With Standard First Line Treatments in HER2+ MBC / cancer, Dana-Farber Cancer Institute, Elad Sharon, OncoDaily, Oncology, Paolo

Median PFS With Standard First Line Treatments in HER2+ MBC - Paolo Tarantino (@ptarantinomd.bsky.social)

oncodaily.com/voices/paolo...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews

OncoDaily

@oncodaily.bsky.social

3 days ago

First Patients Treated with RYZ401 - Huntsman Cancer Institute - OncoDaily First Patients Treated with RYZ401 - Huntsman Cancer Institute / cancer, Heloisa S., Huntsman Cancer Institute, Jeffrey Yap, OncoDaily, Oncology, RYZ401

First Patients Treated with RYZ401 - Huntsman Cancer Institute

@huntsmancancer.bsky.social

oncodaily.com/voices/hunts...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews

OncoDaily

@oncodaily.bsky.social

3 days ago

Paolo Tarantino: TROPION-Breast02 Evaluates Dato-DXd in mTNBC - OncoDaily Paolo Tarantino: TROPION-Breast02 Evaluates Dato-DXd in mTNBC / A. Patera, A. Stradella, Á. Wéber, Annals of Oncology, Breast Cancer, cancer, D.W. Cescon,

TROPION-Breast02 Evaluates Dato-DXd in mTNBC - Paolo Tarantino

@ptarantinomd.bsky.social

oncodaily.com/voices/paolo...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews

OncoDaily

@oncodaily.bsky.social

3 days ago

The Lancet Regional Health – Eastern Mediterranean: New Open Access Journal - OncoDaily The Lancet Regional Health – Eastern Mediterranean: New Open Access Journal / cancer, OncoDaily, Oncology, Sarah Aleyan, The Lancet Group, The Lancet Regional

The Lancet Regional Health – Eastern Mediterranean: New Open Access Journal

@thelancet.com

oncodaily.com/voices/the-l...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews

OncoDaily

@oncodaily.bsky.social

4 days ago

Fellows of the AACR Academy to Be Recognized at AACR26 Opening Ceremony - OncoDaily Fellows of the AACR Academy to Be Recognized at AACR26 Opening Ceremony / AACR, AACR26, cancer, OncoDaily, Oncology

Fellows of the AACR Academy to Be Recognized at AACR26 Opening Ceremony

@theaacr.bsky.social

oncodaily.com/voices/aacr-...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews

OncoDaily

@oncodaily.bsky.social

4 days ago

ASCO Breakthrough 2026 to Convene Global Oncology Community in Singapore - OncoDaily ASCO Breakthrough 2026 to Convene Global Oncology Community in Singapore / ASCO, ASCOBT26, cancer, Clifford Hudis, Elizabeth Mittendorf, Eric Small, Julie

ASCO Breakthrough 2026 to Convene Global Oncology Community in Singapore

@cliffordhudis.bsky.social @jrgralow.bsky.social @ascocancer.bsky.social @ericsmall.bsky.social

oncodaily.com/voices/asco-...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews

OncoDaily

@oncodaily.bsky.social

4 days ago

Jad Chahoud: Fawzi Abu Rous on Drug Development from First-in-Human to FDA Approval - OncoDaily Jad Chahoud: Fawzi Abu Rous on Drug Development from First-in-Human to FDA Approval / cancer, drug development, Fawzi Abu Rous, Henry Ford Health, Jad

Fawzi Abu Rous on Drug Development from First-in-Human to FDA Approval - Jad Chahoud

@henryfordhealth.bsky.social @orlandohealth.bsky.social

oncodaily.com/voices/jad-c...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #DrugDevelopment